| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |